The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 18, 2011

Filed:

Sep. 26, 2001
Applicants:

Kim Pettersson, Turku, FI;

Hans Lilja, Skanör, SE;

Timo Lövgren, Turku, FI;

Pauliina Niemelä, Turku, FI;

Inventors:

Kim Pettersson, Turku, FI;

Hans Lilja, Skanör, SE;

Timo Lövgren, Turku, FI;

Pauliina Niemelä, Turku, FI;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C07K 17/00 (2006.01); C12P 21/08 (2006.01); G01N 33/53 (2006.01); G01N 33/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

This invention concerns an antibody which binds with high affinity to human single-chain intact, i.e. not internally cleaved, mature and/or zymogen forms of prostate specific antigen (SCINT PSA). The antibody does not bind to a nicked PSA (PSA-N), wherein said PSA-N has been formed by internal peptide bond cleavage(s) of SCINT PSA resulting in two-chain or multi-chain PSA. This invention further concerns an immunoassay and a method for differentiating patients with cancer of the prostate (PCa) from patients with benign prostatic hyperplasia (BPH) and/or healthy male subjects without PCa, patients with aggressive PCa from patients with indolent PCa and/or patients with clinically localized and/or organ confined PCa from patients with extraprostatic extension of PCa and/or PCa with metastatic spread to lymph nodes or bone marrow using said antibody.


Find Patent Forward Citations

Loading…